Issues S$90m five-year senior unsecured bond bearing a fixed 3.54% coupon, rated AA by S&P Global Ratings Unconditionally and irrevocably guaranteed by the Credit Guarantee and Investment Facility ("CGIF"), a trust fund of the Asian Development Bank More than 4 times oversubscribed with very robust interest from leading global institutional investors Proceeds to be used towards refinancing existing loans and facilitate strategic expansion of its market leadership positions in key segments including diagnostic imaging, oncology and women's health in Singapore and across Asia Plans to leverage partnership with global IVF leader CHA Medical Group and SMG's pan-Pacific footprint to become a market leader in assisted reproductive medicine SINGAPORE , Nov. 20, 2024 /PRNewswire/ -- Singapore Medical Group ("SMG" or "the Group"), a multidisciplinary specialist healthcare services provider, has completed a S$90 million , 5-year senior unsecured bond issuance at a 3.
54% fixed rate due in 2029. The bond is unconditionally and irrevocably guaranteed by the Credit Guarantee and Investment Facility ("CGIF"), a trust fund of the Asian Development Bank, and assigned a rating of AA by S&P Global Ratings. The issuance process generated robust market interest and was more than 4 times oversubscribed, backed by strong demand from leading global institutional investors including Blackrock, Aberdeen, Everspring, SingLife and Brunei Central Bank.
The Group intends to use the net issuance proceeds t.
